Institute of Personalized Medicine (IPM)
Pharmacogenomics aims at understanding how variations in the human genome affect the response to medications.
Our researchers are working to generate new knowledge, and to develop tools and algorithms that can help in personalizing medicine utilizing a patient’s genetic profile and other factors to achieve maximum therapeutic benefit with minimum toxicity.
News
Pharmacogenomics Conference 2020
The 2020 University of Minnesota Biennial Pharmacogenomics Conference is going virtual! The conference was previously scheduled for June but has moved to an online format this fall. Mark your calendars to join us Sept. 10-11.
This two-day virtual conference is designed for healthcare professionals such as pharmacists, physicians, nurses, physician assistants, mental health providers, program managers and genetic counselors who are interested in bringing PGx into practice.
Using live lectures from experts (with Q&A sessions), moderated small-group breakout discussions, a virtual exhibit hall and a virtual poster session, Implementation of Pharmacogenomics into Clinical Care will provide participants with both general knowledge and best practices to support clinical PGx. Register now through September 9, 2020.
MINNEAPOLIS/ST. PAUL (08/27/2020) — Over the past few months, a number of drugs have been under investigation to treat COVID-19 without well-established safety or data to support these claims. However, some of these unproven therapies may have underlying genetic reasons for not being effective and resulting in fatal adverse effects as found with hydroxychloroquine.
The University of Minnesota College of Pharmacy mourns the loss of Don Uden, PharmD, professor in the Department of Pharmaceutical Care & Health Systems, who died on Saturday, March 21.
The University of Minnesota College of Pharmacy has ranked third in this year’s U.S.News and World Report’s ranking of pharmacy schools.
Weekly Genomics Scan
This weekly update features emerging roles of human genomics, testing and interventions in a wide variety of noncommunicable diseases across the life span.
Precision Medicine Seminar Series
"Real-World Data of Immunotherapy in Non-Small Cell Lung Cancer: Evidence for a Precision Medicine Approach?"
David Stenehjem, PharmD, BCOP
Associate Professor and Associate Department Head in the Department of Pharmacy Practice and Pharmaceutical Sciences at the University of Minnesota
Friday, October 2
2 PM - 3 PM, presented online via Zoom
Dr. Stenehjem is a member of the Masonic Cancer Center at the University of Minnesota and co-director of a pharmacogenomic implementation fellowship program in partnership with Essentia Health in Duluth. More information...
The webinar is offered to attendees at no cost. We hope you’ll join us!
(The above link will redirect to the live seminar on Zoom approximately 10 minutes before the start time.)
Pharmacogenomics
Conference
Genomic Testing to Individualize Drug Therapy
The 2018 Pharmacogenomics Conference on June 22 was at capacity with over 310 registrants in attendance. Topics included: cancer somatic mutations and selection of targeted therapies, emerging PGx areas. Read about the event here.
University Precision Medicine Initiatives
Precision Medicine and Health Consortium (PMHC)
Bringing together scientists, healthcare providers, patients and payers in the area of precision medicine to promote research, education and the use of precision medicine and health to improve human health.
Minnesota Precision Medicine Collaborative (MPMC)
Transforming health and advancing equity by generating precision treatments of disease to advance health outcomes for all Minnesotans.